Advanced Search
Contact | Corporate | Help

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

Sponsors:
  • Columbia University
  • Wyeth
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Triple Negative Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Temsirolimus, cisplatin, erlotinib
Enrollment:
18

Additional information about NCT00998036.


SourceSolution © 2008-2012